Publications Le 07 Déc 2020 Publications Filtrer nos publications par : Année2025202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001 2021 Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke. In acute ischemic stroke, the only FDA-approved drug; recombinant tissue plasminogen activator (rt-PA) is limited by restricted time-window due to (…) Consulter 2011 Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence. About 15 million strokes occur each year worldwide. As the number one cause of morbidity and acquired disability, stroke is (…) Consulter 2015 Letter by Gauberti and Vivien regarding article, "amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice". Consulter 2016 The plasminogen activation system in neuroinflammation. The plasminogen activation (PA) system consists in a group of proteases and protease inhibitors regulating the activation of the zymogen (…) Consulter 2016 A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. Stroke represents a global challenge and is a leading cause of permanent disability worldwide. Despite much effort, translation of research (…) Consulter 2016 Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis. Multiple sclerosis is among the most common causes of neurological disability in young adults. Here we provide the preclinical proof (…) Consulter Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596Load More Retour
